FUNDC1/PFKP-mediated Mitophagy Induced by KD025 Ameliorates Cartilage Degeneration in Osteoarthritis

Guibin Fang,Xingzhao Wen,Zongrui Jiang,Xue Du,Ruonan Liu,Chengyun Zhang,Guiwu Huang,Weiming Liao,Zhiqi Zhang

DOI: https://doi.org/10.1016/j.ymthe.2023.10.016

IF: 12.91

2023-01-01

Molecular Therapy

Abstract:Osteoarthritis (OA) is the most common joint disease, but no disease-modifying drugs have been approved for OA treat-ment. Mitophagy participates in mitochondrial homeostasis regulation by selectively clearing dysfunctional mitochondria, which might contribute to cartilage degeneration in OA. Here, we provide evidence of impaired mitophagy in OA chon-drocytes, which exacerbates chondrocyte degeneration. Among the several classic mitophagy-regulating pathways and recep-tors, we found that FUNDC1 plays a key role in preserving chondrocyte homeostasis by inducing mitophagy. FUNDC1 knockdown in vitro and knockout in vivo decreased mitophagy and exacerbated mitochondrial dysfunction, exacerbating chondrocyte degeneration and OA progression. FUNDC1 over -expression via intra-articular injection of adeno-associated vi-rus alleviated cartilage degeneration in OA. Mechanistically, our study demonstrated that PFKP interacts with and dephos-phorylates FUNDC1 to induce mitophagy in chondrocytes. Further analysis identified KD025 as a candidate drug for restoring chondrocyte mitophagy by increasing the FUNDC1-PFKP interaction and thus alleviating cartilage degeneration in mice with DMM-induced OA. Our study high-lights the role of the FUNDC1-PFKP interaction in chondro-cyte homeostasis via mitophagy induction and identifies KD025 as a promising agent for treating OA by increasing chondrocyte mitophagy.